1.Cribriform-morular thyroid cancer: report of a case.
J Q WANG ; D CHEN ; W FANG ; J F SHANG ; M H ZHENG ; F DONG
Chinese Journal of Pathology 2023;52(10):1061-1063
2.Fatal macrofollicular variant of papillary thyroid carcinoma:report of a case.
Jue WANG ; Sha FU ; Huan WAN ; Na Fen ZHENG ; Neng Tai OUYANG ; Zhong GUAN ; Hong ZENG
Chinese Journal of Pathology 2022;51(11):1174-1177
5.Papillary carcinoma in a thyroglossal duct remnant: a case report.
Jiao ZHOU ; Qiongling HUANG ; Ming LU ; Shuqiang CHU ; Yizheng ZHANG ; Chaohui ZHENG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(6):491-493
This case report has described a case of papillary carcinoma of thyroglossal duct in a young male. This patient was admitted with a mass in the anterior neck for 2 years. Preoperative Bultrasonography, CT and MR showed a subcutaneous cystic mass with irregular calcification shadow in the central region of the neck without obvious enhancement. Initial diagnosis was thyroglossal duct cyst, and was excised by Sistrunk under general anesthesia. The postoperative pathological examination showed thyroglossal duct cyst combined with thyroid papillary carcinoma, which was confirmed by immunohistochemistry as thyroglossal duct papillary carcinoma.
Humans
;
Male
;
Thyroid Neoplasms/surgery*
;
Carcinoma, Papillary/pathology*
;
Thyroglossal Cyst/surgery*
;
Thyroid Cancer, Papillary
6.Diagnosis and treatment of thyroid microcarcinoma.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(24):1911-1917
Papillary thyroid microcarcinoma (PTMC) is defined as a papillary thyroid carcinoma measuring less than 10 mm in diameter. With the development of ultrasonic technology and the popularization of physical examination, the incidence of PTMC increased dramatically. Routine preoperative diagnostic methods include clinical examination, thyroid ultrasound and fine needle aspiration biopsy. But its treatment methods are still controversal. In this paper, we review literatures in recent years and discuss the clinical common problems of PTMC.
Biopsy, Fine-Needle
;
Carcinoma
;
diagnosis
;
surgery
;
Carcinoma, Papillary
;
diagnosis
;
surgery
;
Humans
;
Incidence
;
Thyroid Cancer, Papillary
;
Thyroid Neoplasms
;
diagnosis
;
surgery
;
Thyroidectomy
7.Surgical treatment of papillary thyroid carcinoma involving larynx and trachea.
Tong Liang XIA ; Chen Yang XU ; Dong Min WEI ; Ye QIAN ; Wen Ming LI ; Xin Lang PAN ; Da Peng LEI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2022;57(9):1059-1065
Objective: To evaluate the efficacy of surgical treatment of papillary thyroid carcinoma (PTC) involving larynx and trachea. Methods: A total of 1 436 cases of thyroid malignant tumors were admitted to the Department of Otolaryngology, Qilu Hospital of Shandong University from 2004 to 2019, including 110 cases of PTC involving larynx and trachea, and of which 105 cases with complete follow-up data were retrospectively analyzed. There were 42 males and 63 females, with a male/female ratio of 1∶1.5, aged from 28 to 81 years. All lesions involved trachea, including 11 cases involving both trachea and larynx. Of those 83 cases underwent laryngeal and airway wall tumor excision, and 22 cases underwent radical tumor excision plus laryngeal and trachea repair. Extubation rate was analyzed and the postoperative survival curve of patients was analyzed by Kaplan-Meier method. Results: Among 105 cases, 16 cases underwent tracheotomy and 12 cases were successfully extubated. The overall 3- 5- and 10-year survival rates were 100.0%, 86.4% and 72.5%, and the disease-free survival rates were 93.1%, 81.6% and 57.7%, respectively. There was significant difference in survival curve between the two groups (χ2=4.21, P=0.040). The 5-year and 10-year survival rates were 94.6% and 77.3% in laryngeal and tracheal tumor exclusion group, and 85.7% and 51.4% in the radical tumor resection group. There was no significant difference in the survival curves between the two groups (χ2=3.50, P=0.061). Conclusion: PTC patients with laryngeal and tracheal involvement can achieve long survival and good quality of life through reasonable surgical treatment.
Female
;
Humans
;
Larynx/surgery*
;
Male
;
Neoplasm Invasiveness
;
Quality of Life
;
Retrospective Studies
;
Thyroid Cancer, Papillary/surgery*
;
Thyroid Neoplasms/pathology*
;
Trachea/surgery*
8.Predictive value of PTH level on day 1 after surgery for papillary thyroid carcinoma in patients with permanent hypoparathyroidism.
Jinwei GAO ; Qi ZHANG ; Zesheng WANG ; Yibin GUO ; Shengchang LIANG ; Yupeng ZHANG ; Kunpeng QU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(5):365-369
Objective:To investigate the relationship between parathyroid hormone(PTH) level and permanent hypoparathyroidism(PHPP) on the first day after radical papillary thyroidectomy, and its predictive value. Methods:A total of 80 patients with papillary thyroid cancer who underwent total thyroid resection and central lymph node dissection were collected and analyzed from January 2021 to January 2022. According to whether PHPP occurred after surgery, the patients were divided into hypoparathyroidism group and normal parathyroid function group, and univariate and binary logistics regression were used to analyze the correlation between PTH and serum calcium levels and PHPP on the first day after surgery in two groups. The dynamic changes of PTH at different time points after operation were analyzed. The area under the receiver operating characteristic was used to evaluate the predictive power of PTH on the development of PHPP after surgery. Results:Among the 80 patients with papillary thyroid cancer, 10 cases developed PHPP, with an incidence rate of 12.5%. Binary logistics regression analysis showed that PTH on the first postoperative day(OR=14.534, 95%CI: 2.377-88.858, P=0.004) was an independent predictive risk factor for postoperative PHPP. Taking PTH=8.75 ng/L on the first postoperative day as the cut-off value, the AUC of the area under the curve was 0.874(95%CI: 0.790-0.958, P<0.001), the sensitivity was 71.4%, the specificity was 100%, and the Yoden index was 0.714. Conclusion:PTH level on the first day after total thyroid papillary carcinoma surgery is closely related to PHPP, and is an independent predictor of PHPP.
Humans
;
Calcium
;
Hypoparathyroidism/surgery*
;
Parathyroid Glands
;
Parathyroid Hormone
;
Postoperative Complications/surgery*
;
Thyroid Cancer, Papillary/surgery*
;
Thyroid Neoplasms/complications*
;
Thyroidectomy
9.The significance of lymph node dissection in the VI area of cN0 thyroid papillary carcinoma.
Wencheng DAI ; Bin JIANG ; Weixian CHEN ; Lian HAN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2016;30(4):319-321
OBJECTIVE:
The significance of lymph node dissection in the VI area of cN0 thyroid papillary carcinoma.
METHOD:
Collect 150 cases of patients diagnosed with cNO thyroid papillary carcinoma and they were performed thyroid gland lobe and isthmic portion excision including lateral VI area lymph node cleaning. The specimens were pathologic examined to determinate the size, the position, invasion of thyroid papillary carcinoma,the number and metastasis of lymph node, etc.
RESULT:
In the 150 patients performed the lymph node VI area groups cleaning, 93 cases had VI area of lymph node metastases, so the transfer rate was 62.0%. In the VI area, metastasis rate of tracheal side lymph nodes was 62.0% (93/150), lymph node before throat group was 4.67% (7/150), lymph node before trachea group was 3.33% (5/150), lymph nodes near the trachea laryngeal recurrent nerve ventral group was 52.0% (78/150), and next to the trachea laryngeal recurrent nerve dorsal lymph node group was 21.33% (32/ 150).
CONCLUSION
In CN0 thyroid papillary carcinoma, VI zone of lymph node metastasis rate is high, and region VI lymph node metastasis rate from high to low in order for: paratracheal lymph node, prelaryngeal lymph node, pretracheal lymph node. The metastasis rate of paratracheal throat back nerve ventral lymph node was the highest in central lymph node.
Carcinoma
;
pathology
;
surgery
;
Carcinoma, Papillary
;
pathology
;
surgery
;
Humans
;
Lymph Nodes
;
pathology
;
Lymphatic Metastasis
;
Neck
;
Neck Dissection
;
Recurrent Laryngeal Nerve
;
Thyroid Cancer, Papillary
;
Thyroid Neoplasms
;
pathology
;
surgery
10.Preliminary experience of robotic lateral neck dissection via combined axillary-retroauricular approach for N1b papillary thyroid carcinoma.
Fa Ya LIANG ; Ping HAN ; Pei Liang LIN ; Ren Hui CHEN ; Jing Yi WANG ; Xiao Ming HUANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2022;57(9):1072-1078
Objective: To evaluate the feasibility, safety, and short-term efficacy of robotic lateral neck dissection via combined axillary-retroauricular approach for N1b papillary thyroid carcinoma (PTC). Methods: Thirty patients with cT1-2N1bM0 PTC who received robotic lateral neck dissection via combined axillary-retroauricular approach were included in the Department of Otorhinolaryngology of Sun Yat-sen Memorial Hospital from December 2016 to December 2020. There were 10 males and 20 females, with a median age of 34.5 years and a median body mass index of 25.55 kg/m2. The clinical, surgical, complications, pathology and follow-up data were analysed with SPSS 25.0 software package. Results: The median operative time of 30 patients was 255.50 min, the median operative blood loss was 69.00 ml, and the median postoperative hospital stay was 6.00 days. The incidence of postoperative temporary recurrent laryngeal nerve paralysis was 3.33% (1/30), temporary hypoparathyroidism was 16.67%(5/30), temporary accessory nerve injury was 3.33% (1/30), hematoma was 3.33% (1/30) and chylous leakage was 3.33% (1/30). The median visual analogue scale (VAS) score was 8.00, and the follow-up time was 13-38 months, with a median of 25.5 months. One case showed cervical lymph node recurrence 14 months after surgery. The most recent dynamic recurrence risk stratification showed 21 patients (70.00%) had excellent responses. Conclusions: Robotic lateral neck dissection via combined axillary-retroauricular approach for unilateral cN1b PTC is safe, feasible and aesthetic. The short-term efficacy and dynamic recurrence risk stratification results of short-term follow-up are satisfactory. It can provide a surgical option for cN1b PTC patients.
Adult
;
Carcinoma, Papillary/surgery*
;
Female
;
Humans
;
Male
;
Neck Dissection/methods*
;
Retrospective Studies
;
Robotic Surgical Procedures
;
Thyroid Cancer, Papillary/surgery*
;
Thyroid Neoplasms/surgery*
;
Thyroidectomy/methods*